Disease Biology Services
-
Manufactured by Mimetas B.V.based in NETHERLANDS
Capture and understand human disease biology in vitro. The key to unlocking effective therapies for the unsolved diseases of our times is a deep understanding of human disease biology. To this end, MIMETAS aims to capture the essence of diseases in fit-for-purpose in vitro models. We are fully ...
-
by Kumudabased in USA
Innovation. Not just iteration. Disease biology is complex. Innovative integrated approaches are needed to unlock promising disease treatments. Kumuda is a therapeutics company that accelerates and de-risks novel small molecule drug discovery and development by applying an integrated multi-dimensional ...
-
Manufactured by Veracytebased in FRANCE
Leverage the widely used Nanostring platform to study gene expression in the tumor microenvironment, revealing biomarker signatures, mechanism of action, disease biology, and more. The most popular Nanostring service we offer is the nCounter® PanCancer IO 360™ Panel. This panel is designed to deliver immuno-oncology ...
-
by Genmab A/Sbased in DENMARK
treatments. Our research and innovation teams consist of a strong antibody discovery engine connecting our antibody platform technologies with our target and disease biology knowledge. This synergy is the lifeblood of our R&D organization, where our creations enter clinical ...
-
Manufactured by Galera Therapeutics, Inc.based in USA
The cornerstone of our work is the recognition that oxygen metabolic pathways play important roles in human biology and ...
-
by Amgen Inc.based in USA
To support Amgen’s mission of serving patients, the R&D organization aims to discover, develop, and deliver transformative medicines that address the leading causes of death and disability, working to meet the needs of as many patients as possible. To achieve this vision, we need to take full advantage of opportunities arising from rapid scientific progress and new technologies. ...
-
Manufactured by Kymab, a Sanofi companybased in UNITED KINGDOM
Our efforts in haematology are currently focussed on non-malignant blood disorders including forms of anaemia. Our approach is to identify functional and developable lead molecules and quickly proceed to verified animal disease models to study the direct impact of our drug candidates with clinically relevant read outs. We build our ...
-
by Biodesixbased in USA
Working alongside our biopharmaceutical partners, we employ personalized and integrated approaches to uncover new solutions to diagnostic challenges with industry-leading expertise in blood-based ...
-
based in SWITZERLAND
Leading-edge therapies that leverage the microbiome promise to address a range of serious diseases that currently don’t have adequate solutions. Microbiome-based therapies are de-risked thanks to the established proof-of-concept with fecal matter transplant ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you